Originator recombinant human follitropin alfa versus recombinant human follitropin alfa biosimilars in Spain: A cost-effectiveness analysis of assisted reproductive technology related to fresh embryo transfers-Reference-Cited by-同舟云学术

Originator recombinant human follitropin alfa versus recombinant human follitropin alfa biosimilars in Spain: A cost-effectiveness analysis of assisted reproductive technology related to fresh embryo transfers

Published:2022-12 Issue: Volume:85 Page:203-216
ISSN:1521-6934
Container-title:Best Practice & Research Clinical Obstetrics & Gynaecology
language:en
Short-container-title:Best Practice & Research Clinical Obstetrics & Gynaecology

Author:

Schwarze Juan-Enrique,Venetis Christos,Iniesta Silvia,Falla Edel,Lukyanov Vasily,de Agustin Calvo Elena,D´Hooghe Thomas,Roeder Claudia,Matorras Roberto

Publisher

Elsevier BV

Reference20 articles.

1. The development of gonadotropins for clinical use in the treatment of infertility;Lunenfeld;Front Endocrinol,2019

3. Biosimilar recombinant follicle stimulating hormones in infertility treatment;Santi;Expert Opin Biol Ther,2014

4. Safety and efficacy of Ovaleap(R) (recombinant human follicle-stimulating hormone) for up to 3 cycles in infertile women using assisted reproductive technology: a phase 3 open-label follow-up to Main Study;Strowitzki;Reprod Biol Endocrinol,2016

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. A Cost-Effectiveness Analysis of Gonadotropins Used for Ovarian Stimulation during Assisted Reproductive Technology Based on Data from the French Nationwide Claims Database (SNDS);Gynecologic and Obstetric Investigation;2024-11-19

3. Economic evaluation of GnRH-agonist long protocol and GnRH-antagonist protocol in IVT/ICSI among the Chinese population: using pharmacoeconomic models;BMJ Open;2024-08

4. Determining the cost-effectiveness of follitropin alfa biosimilar compared to follitropin alfa originator in women undergoing fertility treatment in France;European Journal of Obstetrics & Gynecology and Reproductive Biology: X;2024-06

5. Systematic review of the economic evaluation model of assisted reproductive technology;Health Economics Review;2024-05-20